AIRÒ P

Last name: AIRÒ P

2015 (v1)

Publication

Metadata-only

Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population.

Hachulla E Clerson P Airò P

No description

Uploaded on: April 14, 2023
2020 (v1)

Publication

Metadata-only

Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database.

Allanore Y Bozzi S Terlinden A

No description

Uploaded on: April 14, 2023
2023 (v1)

Publication

Metadata-only

Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region.

Lescoat A Huscher D Schoof N

No description

Uploaded on: January 31, 2024
2022 (v1)

Publication

Metadata-only

Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: a study from the EUSTAR cohort.

Hughes M Heal C Henes J

No description

Uploaded on: February 14, 2024
2022 (v1)

Publication

Metadata-only

Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from EUSTAR cohort.

Zanatta E Huscher D Ortolan A

No description

Uploaded on: February 4, 2024
2017 (v1)

Publication

Metadata-only

Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis.

Galli M Antinori S Atzeni F

No description

Uploaded on: April 14, 2023
2017 (v1)

Publication

Metadata-only

Mapping and predicting mortality from systemic sclerosis.

Elhai M Meune C Boubaya M

No description

Uploaded on: April 14, 2023
2019 (v1)

Publication

Metadata-only

Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort.

Wu W Jordan S Graf N

No description

Uploaded on: April 14, 2023
2019 (v1)

Publication

Metadata-only

Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis.

Becker M Graf N Sauter R

Objectives Mortality and worsening of organ function are desirable endpoints for clinical trials in systemic sclerosis (SSc). The aim of this study was to identify factors that allow enrichment of patients with these endpoints, in a population of patients from the European Scleroderma Trials and Research group database. Methods Inclusion...

Uploaded on: April 14, 2023

AIRÒ P

Recent uploads